ArticleBMJ open2025
Postmarketing adverse events of efgartigimod alfa: a real-world pharmacovigilance study based on the FAERS database.
Yaxin Ju et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papertrialcites it